Episurf Medical

Episurf Medical AB (NASDAQ: EPIS B) has, pursuant to previously announced information, carried out a rights issue of units consisting of shares of series B and warrants of series TO13 B. The rights issue has resulted in a change in the number of shares and votes in the company. Through the rights issue, the number of shares has increased by 375,662,430 shares of series B and the number of votes has increased by 375,662,430.

Furthermore, the company has, pursuant to previously announced information, carried out a set-off issue of units consisting of shares of series B and warrants of series TO13 B directed to certain guarantors in the rights issue. The set-off issue has resulted in a change in the number of shares and votes in the company. Through the set-off issue, the number of shares has increased by 8,749,965 shares of series B and the number of votes has increased by 8,749,965.

As a consequence of the above-mentioned changes, the total number of shares amounts to 651,477,842, of which 473,357 are shares of series A and 651,004,485 are shares of series B, and the total number of votes amounts to 652,424,556.